The speed with which IV diuretics were administered to people with acute heart failure (AHF) didn’t appear to make a difference in short- or intermediate-term mortality rates, according to a study of 2,761 Korean patients.

Todd A. Trapp will take over as CFO of Abiomed on April 9, the company announced March 30.

Patients who developed new-onset postoperative atrial fibrillation (POAF) after coronary artery bypass graft (CABG) surgery showed a 33 percent reduced risk of thromboembolism long-term when compared to those with nonsurgical AFib, according to a study published March 28 in JAMA Cardiology.

ABBOTT PARK, Ill., March 29, 2018 — Abbott (NYSE: ABT) announced today the company has initiated the landmark GUIDE-HF clinical trial using the CardioMEMS™ HF System. The GUIDE-HF trial will study whether the CardioMEMS device can improve survival and quality of life for people living with New York Heart Association (NYHA) Class II – IV heart failure.

The YMCA and American Heart Association (AHA) are launching a collaborative effort this spring to help combat hypertension. Through the new partnership, clinics participating in the AHA and American Medical Association’s national Target: BP initiative can refer patients to the YMCA for free support in learning how to self-monitor their blood pressure.

Bioprosthetic heart valves used in surgical aortic valve replacement (SAVR) procedures in the early 2000s demonstrated “satisfactory” durability, according to a single-center study published in the Journal of the American College of Cardiology.

Damaged tissue resulting from myocardial infarction could one day be repaired with specially engineered patches seeded with cardiac cells to encourage the regeneration of healthy cells in the muscle.

A high dose of oral ibuprofen appeared to be the best option for closing patent ductus arteriosus (PDA) in a meta-analysis of 4,802 preterm infants, researchers reported in JAMA.